Genostics® is an Australian medical diagnostic, education and consultancy company.
We partner with world-class cancer research laboratories in Europe to bring the very best in personalised cancer testing to the Australian and New Zealand medical communities.
We engage with pioneering practitioners who seek to discover the exact nature of each patient's cancer. These practitioners use Genostics® tests to help design personalised treatment plans and to closely monitor the effectiveness of therapies.
Specialising in the field of Oncology, we are proud to be bringing the future of personalised caner testing to patients, today
A growing tumour is made up of many different cancer cells. If a cancer is malignant, a select population of cancer cells can escape the tumour mass and invade the blood stream. When this happens, the cancer is at a turning point. Escapee cancer cells in the blood stream can travel to another site in the body and grow a second tumour at a later stage, called a metastasis. These escapee cancer cells in the blood are called Circulating Tumour Cells, abbreviated as ‘CTCs.’
Escapee cancer cells in the blood can be found by a simple blood test.
The effectiveness of cancer therapy can now be monitored
"There is increasing evidence that CTCs reflect cancer progression in real time and that this information may be particularly helpful in the context of systemic therapies. In the future, CTC characterisation is expected to contribute to guiding specific targeted therapies to a defined population of cancer patients within a certain therapeutic window...
- which is the hallmark of personalized medicine." - Clin Chem 2012